Beta-blockers May Reduce Mortality Rate for Patients with Heart, Kidney Failure

For patients with both heart and kidney failure, beta-blocker use was associated with decreased mortality rates within 1 year after dialysis initiation.

According to Hui Zhou, PhD, of the department of research and evaluation at Kaiser Permanente Southern California, and colleagues, beta-blocker therapy is generally thought to be beneficial to patients with chronic kidney disease. However, they contended that less is known about its impact on patients once they progress to end-stage kidney disease and must transition to dialysis.

Read the full article, here.